Setup

D.R. Horton (DHI, ≈$45B mkt cap) is the largest US homebuilder by volume, weighted to entry-level. Q2 FY2026 10-Q (filed April 23, 2026) confirmed +11% order growth — a sector outlier — alongside -170bps gross margin compression and an effective tax rate step-up that did not appear at peers. Six executives bought ≈$2.2M two trading days before the print at $162. The contradiction is the thesis.

What the filing says

Net orders +11% YoY (24,992 homes), backlog +19% (16,882 homes, $6.4B value). Volume acceleration outpaces every Big-3 peer (PHM +3%, LEN +1%) and every mid-cap (TMHC -13.6%, MTH -5%, KBH -14% deliveries).

Home sales gross margin 20.1% vs 21.8% PY (-170bps). Management explicit: "We expect our incentive levels to stay elevated during fiscal 2026." No H2 margin recovery guided. EPS $2.24 vs $2.58 (-13%). Revenue -2.3%.

Effective tax rate 24.1% Q2 FY26 vs 23.2% Q2 FY25 — +90bps (H1 +120bps to 24.4%). DHI does not explicitly disclose the OBBBA Section 45L energy-efficient home tax credit cliff (June 30, 2026) anywhere in the filing — boilerplate language unchanged. The ETR step-up is the first numeric tell that 45L benefit is already eroding.

Cross-ticker check on Q1 2026 peer 10-Qs already filed: PHM ETR -40bps, LEN -150bps (one-time charitable), TMHC -10bps. DHI is the lone large-cap homebuilder showing material ETR step-up. Critically, DHI's Q2 step-up occurred 3 months before the cliff, so it reflects either conservative accrual reduction in anticipation, per-home 45L benefit decline as DHI's mix shifts, or DHI-specific tax composition.

Spec inventory normalized -41% (9,300 → 5,500 unsold completed homes). Credit facility expanded 43% in March ($2.305B → $3.295B, extended to 2031). March buybacks 2.26M shares at $142.56 — highest count and lowest price of the quarter (loaded into the selloff). Mortgage repurchase facility ($1.4B) matures May 6, 2026; "in discussions with lenders to renew."

Zero tariff mentions in the entire 10-Q. DHI is now 4-for-4 silent across Q1/Q2 8-Ks and 10-Qs. The Big-3 silence pattern holds while mid-caps disclose explicitly.

What the market thinks

Mean analyst target $165 (+2% from recent close); analyst dispersion $123-$206. Vol structure inverted -18% slope; mid-tenor IV (May/June) at 38-44% vs spot 35.8% — market pricing event premium into Q3 print July 21. P/C OI 4.01 with puts mostly OTM at $120-140 (tail hedges, not directional shorts).

Forward P/E ≈17.9x on FY26 EPS estimate ≈$9.00. PHM trades ≈10x, LEN ≈12x. The premium reflects DHI's growth and share-gain track record. Sell-side consensus likely embeds sector-uniform tax-rate normalization and 45L benign treatment.

Probability-weighted intrinsic estimate: $117-140 (range; central ≈$130). At recent levels, stock is 13-23% above central intrinsic. Directional 12-month EV after dividend: ~-7%.

Why the gap exists

The market hasn't synthesized two cross-references that take the work to surface:

(1) DHI-specific 45L concentration. The cross-ticker ETR check requires reading PHM, LEN, TMHC Q1 2026 10-Qs and computing the YoY delta. Sell-side tax models default to sector-uniform normalization. The differential — DHI +90bps while peers flat-to-down — is buried in tax footnotes that don't make analyst notes. ASU 2023-09 forces explicit 45L disclosure in DHI's FY26 annual 10-K (Nov 2026), so the gap closes by November regardless. Until then it sits in the data.

(2) Insider cluster Apr 20. Six names — CEO, COO, CFO, Auld, two directors — bought ≈$2.2M at $162 with full knowledge of the print and the cliff. Tier 1 cyclical-trough-cluster pattern. Either insiders see volume offsetting 45L drag, expect OBBBA technical corrections, or believe FY27 expansion absorbs it. Form 4 transaction codes not yet primary-source verified — open market vs grants/exercises matters.

The cleanest expression isolates the 45L differential: long PHM+LEN equal-weight / short DHI dollar-neutral. Probability-weighted pair return ~+4-5% over 12 months. Directional long has negative EV. Directional short fights the insider cluster.

Risks (ranked by impact)

1. OBBBA technical corrections extend 45L (≈20% prob): kills bear thesis. Pair unwinds; stock likely +10-15% on relief.
2. LEN Q2 FY26 ETR step-up matches DHI (≈50% prob, reports late June 2026): sector calendar-offset pattern, DHI-specific thesis dies, pair edge gone.
3. Volume share-gain narrative dominates 45L drag: DHI holds 14-17x multiple on growth premium; stock holds even with cliff.
4. Insider Form 4 codes not "P" (open market): if grants/exercises (codes A/F/M), bullish signal weakens substantially.
5. Mortgage repurchase facility non-renewal May 6 (≈5% prob): binary. 8-K + 5-10% downside.
6. Mississippi PERS Forestar lot pricing suit (Delaware CoC, filed Apr 2025): long-tailed governance risk.

Catalysts

• May 6, 2026: Mortgage repurchase facility renewal (binary)
• Late June 2026: LEN Q2 FY26 print — the disambiguating event
• June 30, 2026: OBBBA 45L statutory cliff
• Late July 2026: DHI Q3 FY26 print — last quarter with 45L benefit; ETR inflection visible
• November 2026: DHI FY26 annual 10-K — ASU 2023-09 forces explicit 45L quantification

What would change our mind

• LEN Q2 FY26 ETR steps up +50bps or more — sector calendar pattern, DHI-specific thesis weakens
• DHI FY24/FY25 10-K disclosures show per-home 45L benefit comparable to peers — no concentration
• OBBBA technical corrections inserted in legislative track — cliff moves or extends
• Form 4 verification shows insider cluster was grants/exercises, not open-market purchases — bull signal degraded
• Stock pulls to $145-150 (50DMA) — directional EV turns positive; pair becomes less attractive vs straight long
• DHI Q3 FY26 GM > 20.5% — incentives easing faster than guided; bull case validation

Evidence